Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
European Journal of Nuclear Medicine and Molecular Imaging
Literatur
1.
Kramer GM, Liu Y, de Langen AJ, Jansma EP, Trigonis I, Asselin MC, et al. Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis. Eur J Nucl Med Mol Imaging. 2018. https://​doi.​org/​10.​1007/​s00259-017-3923-x.
2.
Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med. 2009;50:11S–20S.CrossRefPubMed
3.
Laffon E, de Clermont H, Marthan R, Paycha F. On the 18F-fluoride PET imaging quantification to predict 223Ra-dichloride treatment response. Eur J Nucl Med Mol Imaging. 2018;45:318–20.CrossRefPubMed
4.
Kramer GM, Hoekstra OS, Boellaard R. Reply: Repeatability of quantitative whole-body 18F-FDG PET/CT uptake measures in patients with non-small cell lung cancer: dynamic versus test-retest design. J Nucl Med. 2017;58:1528–9.PubMed
5.
Laffon E, Marthan R. Repeatability of quantitative whole-body 18F-FDG PET/CT uptake measures in patients with non-small cell lung cancer: dynamic versus test-retest design. J Nucl Med. 2017;58:1528.PubMed
Metadaten
Titel
Should we assess repeatability of PET quantitative uptake measurements of each 18F-labelled tracer?
verfasst von
Eric Laffon
Henri de Clermont
Sébastien Buj
Roger Marthan
Publikationsdatum
17.04.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 7/2018
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-018-4006-3

Weitere Artikel der Ausgabe 7/2018

European Journal of Nuclear Medicine and Molecular Imaging 7/2018 Zur Ausgabe

Original Article

Optimal time-point for 68Ga-PSMA-11 PET/CT imaging in assessment of prostate cancer: feasibility of sterile cold-kit tracer preparation?

Image of the Month

68Ga-labelled PSMA (prostate specific membrane antigen) expression in signet-ring cell gastric carcinoma

Original Article

Biological tumour volumes of gliomas in early and standard 20–40 min 18F-FET PET images differ according to IDH mutation status

Editorial

The precise physiological definition of tissue perfusion and clearance measured from imaging

Original Article

Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy

Original Article

68Ga-PSMA-PET/CT imaging of localized primary prostate cancer patients for intensity modulated radiation therapy treatment planning with integrated boost